KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non Operating Investment Income: 2015-2017

  • Teva Pharmaceutical Industries' Non Operating Investment Income was N/A to $3.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $7.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2016, which is 81.82% down from last year.
  • As of Q1 2017, Teva Pharmaceutical Industries' Non Operating Investment Income stood at $3.0 million, which was up 50.00% from $2.0 million recorded in Q4 2016.
  • Over the past 5 years, Teva Pharmaceutical Industries' Non Operating Investment Income peaked at $11.0 million during Q4 2015, and registered a low of $2.0 million during Q4 2016.
  • Moreover, its 3-year median value for Non Operating Investment Income was $3.0 million (2017), whereas its average is $5.3 million.
  • Data for Teva Pharmaceutical Industries' Non Operating Investment Income shows a maximum YoY crashed of 81.82% (in 2016) over the last 5 years.
  • Over the past 3 years, Teva Pharmaceutical Industries' Non Operating Investment Income (Quarterly) stood at $11.0 million in 2015, then plummeted by 81.82% to $2.0 million in 2016, then reached $3.0 million in 2017.
  • Its Non Operating Investment Income was $3.0 million in Q1 2017, compared to $2.0 million in Q4 2016 and $11.0 million in Q4 2015.